Signaturefd LLC cut its holdings in Centene Co. (NYSE:CNC – Free Report) by 8.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,561 shares of the company’s stock after selling 1,022 shares during the period. Signaturefd LLC’s holdings in Centene were worth $795,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. EP Wealth Advisors LLC boosted its holdings in Centene by 1.0% in the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock valued at $1,068,000 after purchasing an additional 133 shares during the period. WR Wealth Planners LLC boosted its holdings in Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares during the period. Whittier Trust Co. boosted its holdings in Centene by 10.0% in the 2nd quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock valued at $104,000 after purchasing an additional 142 shares during the period. Fidelis Capital Partners LLC raised its position in shares of Centene by 5.0% during the 1st quarter. Fidelis Capital Partners LLC now owns 3,316 shares of the company’s stock valued at $260,000 after buying an additional 158 shares in the last quarter. Finally, Bleakley Financial Group LLC raised its position in shares of Centene by 2.4% during the 1st quarter. Bleakley Financial Group LLC now owns 7,287 shares of the company’s stock valued at $572,000 after buying an additional 173 shares in the last quarter. 93.63% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on CNC shares. Truist Financial lowered their price objective on shares of Centene from $92.00 to $89.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. JPMorgan Chase & Co. lowered their price objective on shares of Centene from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Wells Fargo & Company lowered their price objective on shares of Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a research report on Friday, September 13th. Barclays lowered their price objective on shares of Centene from $98.00 to $97.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 target price on shares of Centene in a research report on Tuesday, October 1st. Seven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.58.
Centene Price Performance
CNC stock opened at $61.60 on Friday. The firm’s 50-day moving average price is $73.50 and its two-hundred day moving average price is $72.45. Centene Co. has a 12-month low of $59.77 and a 12-month high of $81.42. The stock has a market capitalization of $32.87 billion, a price-to-earnings ratio of 12.25, a PEG ratio of 0.98 and a beta of 0.48. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64.
Centene (NYSE:CNC – Get Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $2.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.02). Centene had a net margin of 1.79% and a return on equity of 14.45%. The firm had revenue of $39.84 billion during the quarter, compared to analysts’ expectations of $36.83 billion. During the same quarter in the previous year, the firm posted $2.10 EPS. Centene’s revenue was up 5.9% compared to the same quarter last year. As a group, equities analysts predict that Centene Co. will post 6.8 earnings per share for the current year.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- Short Selling: How to Short a Stock
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Insider Buying Explained: What Investors Need to Know
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- EV Stocks and How to Profit from Them
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.